The US FTC collects significant penalties for violations of the pre-merger notification rules after clearing a merger in the market for electronic integratable drug information databases (Hearst / Medi-Span)

It is, of course, too early to tell conclusively whether, and to what extent, antitrust enforcement by the Federal Trade Commission (FTC) and the United States Department of Justice (DOJ) will change under the new Bush administration. Both agencies have indicated that they do not intend to implement any drastic changes and that changes from the Clinton Administration policies will be in the “margins” [1]. However, they have made some comments about their priorities and approaches in the mergers and acquisitions area. These have included strong signals that they intend to challenge transactions, even years after they are consummated, for violations of both competition laws and premerger notification rules, and that the FTC is increasingly going to require a preapproved, capable “up-front

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

James B. Kobak Jr, Renee C. Redman, The US FTC collects significant penalties for violations of the pre-merger notification rules after clearing a merger in the market for electronic integratable drug information databases (Hearst / Medi-Span), 15 October 2001, e-Competitions Bulletin US Mergers in IT, Art. N° 53265

Visites 186

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues